Quantitative Tissue Characterization of Infarct Core and Border Zone in Patients With Ischemic Cardiomyopathy by Magnetic Resonance Is Associated With Future Cardiovascular Events  by Heidary, Shahriar et al.
C
p
p
a
F
o
S
N
D
a
2
Journal of the American College of Cardiology Vol. 55, No. 24, 2010
© 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
PCardiac Imaging
Quantitative Tissue Characterization of
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Ischemic Cardiomyopathy by Magnetic Resonance
Is Associated With Future Cardiovascular Events
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Sandeep N. Gupta, PHD,§ Mihoko V. Bennett, PHD,† Chandra Katikireddy, MD,*
Patricia Nguyen, MD,* John M. Pauly, PHD,‡ Masahiro Terashima, MD, PHD,*
Michael V. McConnell, MD,* Phillip C. Yang, MD*
Stanford, California; and Niskayuna, New York
Objectives This study evaluates how characterization of tissue heterogeneity of myocardial infarction by cardiovascular
magnetic resonance (CMR) is associated with cardiovascular events (CVE) in patients with ischemic cardiomyop-
athy (ICM).
Background Prior studies demonstrated that the quantification of myocardial scar volume by CMR is superior to left ventricu-
lar end-diastolic volume, left ventricular end-systolic volume, and left ventricular ejection fraction (LVEF) in pre-
dicting future CVE in ICM patients. Evaluation of infarct heterogeneity by measuring infarct core and border
zones through CMR might have a higher association with CVE.
Methods Seventy patients (mean LVEF: 25  11%) considered for revascularization or medical management  implant-
able cardiac defibrillator were enrolled. A 1.5-T GE MRI (Signa, GE Healthcare, Milwaukee, Wisconsin) was used
to acquire cine and delayed enhancement images. The patients’ core and border zones of infarcted myocardium
were analyzed and followed for CVE.
Results Larger infarct border zone and its percentage of myocardium were found in the 29 patients (41%) who had CVE
(median 13.3 g [interquartile range (IQR) 8.4 to 25.1 g] vs. 8.0 g [IQR 3.0 to 14.5 g], p  0.02 and 7.8% [IQR
4.9% to 17.0%] vs. 4.1% [IQR 1.9% to 9.3%], p  0.02, respectively). The core infarct zone and its percentage of
myocardium, left ventricular end-diastolic volume, left ventricular end-systolic volume, and LVEF were not statis-
tically significant. Sub-analysis of the medical management and revascularization patients with CVE demon-
strated that the medically managed patients had a larger border zone, whereas there was no difference between
border and core zones in the revascularization group (p  0.05).
Conclusions Quantification of core and border zones and their percentages of myocardium through CMR is associated with
future CVE and might assist in the management of patients with ICM. (J Am Coll Cardiol 2010;55:2762–8)
© 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.01.052a
p
h
w
v
h
h
t
w
r
rongestive heart failure (CHF) has become a widespread
ublic health concern, affecting approximately 5.3 million
atients in the U.S., with nearly 300,000 deaths reported
nnually (1). The most common cause of CHF is coronary
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009, accepted January 2, 2010.rtery disease, and the highest mortality rate is seen in
atients with ischemic cardiomyopathy (ICM) (2). The
igh morbidity and mortality in CHF have been associated
ith a high incidence of ventricular arrhythmia and left
entricular (LV) remodeling (3,4). Myocardial scar tissue
as been linked to ventricular arrhythmia (5–7). Studies
ave also reported that patients with nontransmural infarc-
ions have more cardiovascular events (CVE) than patients
ith transmural infarctions, perhaps suggesting that the
esidual viable myocardium provides the substrate for ar-
hythmias and/or ischemia leading to more CVE (8,9). It
as been well-known that revascularization of these isch-
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June 15, 2010:2762–8 Infarct Heterogeneity in Ischemic Cardiomyopathymic territories results in a lower incidence of ventricular
rrhythmia in patients with ICM (10–13). Recently, tissue
eterogeneity (core and peri-infarct zones) has demon-
trated increased inducibility of sustained monomorphic
entricular tachycardia and to be an independent predictor
f post-myocardial infarction (MI) mortality (9,14).
This study analyzes tissue heterogeneity of MI by quan-
ifying infarct core and border (peri-infarct) zones with
ardiac magnetic resonance (CMR) in patients with chronic
CM and severe LV dysfunction. Quantitative tissue
haracterization to determine future CVE in the entire
tudy population and a sub-analysis of patients undergo-
ng either medical management or revascularization has
een performed.
ethods
atient population. Seventy patients with coronary artery
isease and severe LV dysfunction (left ventricular ejection
raction [LVEF] 50%, mean LVEF 25  11%) consid-
red for revascularization or medication therapy  implant-
ble cardioverter-defibrillator (ICD) were enrolled retro-
pectively; there was no pre-defined enrollment period. All
atients underwent diagnostic coronary angiography before
MR examination. All patients had evidence of prior MI as
ocumented by late gadolinium enhancement (LGE) on
MR. Twenty-nine patients underwent revascularization
21 coronary artery bypass graft [CABG] and 8 percutane-
us coronary intervention [PCI] patients)  ICD place-
ent, and 41 patients received medical therapy  ICD
lacement. The patients were followed for CVE: ventricular
achycardia, ventricular fibrillation or ICD firing, worsening
HF (defined as worse New York Heart Association
unctional class), hospital stay, MI, repeat revascularization,
yncope, and cardiovascular death, with telephone contact
ith patients, their relatives, or the referring physician and
rom review of clinical records. Patients with acute infarc-
ion (within 7 days of magnetic resonance imaging), unsta-
le angina pectoris, asthma, pulmonary disease, severe
alvular disease, or contraindications to the CMR examina-
ion were excluded. The study protocol was approved by the
uman Subjects Committee at Stanford University.
maging protocols. All images were acquired on a 1.5-T
hole-body scanner (Signa, GE Healthcare, Milwaukee,
isconsin) with the patient in a supine position with an
-element phased-array radiofrequency coil with breath-
olding and cardiac gating. Cine images of the LV in short
nd long axes were acquired with a steady-state free preces-
ion sequence (repetition time 3.8, echo time 1.6, flip angle
5°, slice thickness 10 mm, slice gap 0). The LGE images
segmented k-space inversion recovery sequence, repetition
ime 7.1, echo time 3.1, inversion time 200 to 250, slice
hickness 8 to 12 mm) were acquired throughout the entire
V starting at 10 to 20 min, after administration of 0.2
mol/kg of gadolinium diethytriaminepentaacetic acidMagnevist, Schering AG, Germany). The inversion time was fet to null; the signal of normal
yocardium after gadolinium di-
thytriaminepentaacetic acid ad-
inistration was adjusted during
he course of the scan as necessary.
mage analysis. Cine images
ere analyzed with MASS analy-
is software (MASS Analysis Plus
ersion 6.0, Leiden University,
eiden, the Netherlands). Auto-
atic tracing with manual adjust-
ent of endocardial and epicardial
orders from short-axis images
as performed to calculate left
entricular end-diastolic volume
LVEDV), left ventricular end-
ystolic volume (LVESV), LV
nd-diastolic mass, and LVEF.
SSESSMENT OF MI BY LGE. The
otal myocardial and scar area in
ach of the 8 to 12 short-axis
mages (slice thickness 8 to 12
m, gap 0 to 1 mm) were traced
anually as shown in Figure 1.
yocardial and scar volume for
ach slice were calculated as: area
yocardium or area scar  slice
hickness. The scar percentage of
yocardium was also expressed as
percentage of the total myocardial volume: volume scar/
olume myocardium 100. The scar is composed of the inner
ore and outer border zones. In patients with microvascular
bstruction, these hypointense areas were included as scar area.
solated midwall or subepicardial hyperenhancement was ex-
luded, because this was not considered as scar area (16,17).
Multiple methods have been published for quantifying
nfarct scar volume and heterogeneity, including those based
n signal-intensity thresholds specified a priori above a
emote reference segment (14,18). Another method that has
lso been previously published was used in this study and is
escribed in the following text (9). Tissue heterogeneity
nalysis of MI was performed with CineTool software
CineTool version 7.1.2, GE Healthcare) as shown in
igure 2. The maximum signal intensity (SI) within the
nfarct region was determined. Then a region of interest was
rawn in a remote region of myocardium, and the maxi-
um SI within this region was determined. The infarct
ore was defined as the zone with SI 50% of the
aximal SI in the infarct, whereas the border was defined
s the zone with an SI maximum SI in the remote
egion of interest but 50% of maximal SI of the infarct.
he volume of the core and border zones was determined
s described in the preceding text for myocardial and scar
olume, and the tissue mass (g) was calculated by the
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft
CHF  congestive heart
failure
CMR  cardiac magnetic
resonance
CVE  cardiovascular
events
ICD  implantable
cardioverter-defibrillator
ICM  ischemic
cardiomyopathy
IQR  interquartile range
LGE  late gadolinium
enhancement
LV  left ventricular/
ventricle
LVEDV  left ventricular
end-diastolic volume
LVEF  left ventricular
ejection fraction
LVESV  left ventricular
end-systolic volume
MI  myocardial infarction
PCI  percutaneous
coronary interventionollowing: volume (ml)  1.05 (g/ml) (9).
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Infarct Heterogeneity in Ischemic Cardiomyopathy June 15, 2010:2762–8tatistical analysis. Parameters with normal distribution
ere tested by the use of the independent sample t test
2-tailed distribution) and reported as the mean  SD. For
bnormally distributed data (reported as medians and inter-
uartile range [IQR]), Mann-Whitney U test was used.
pearman R (for abnormally distributed data) was calcu-
ated for correlations. Nominal variables were compared
etween groups with the chi-square test or the Fisher exact
est when appropriate. A p value of 0.05 was considered
tatistically significant. All statistical analyses were per-
ormed with the software SPSS version 17.0 (SPSS, Inc.,
hicago, Illinois).
esults
atient characteristics. Clinical and CMR characteristics
f the study population are summarized in Table 1. Twenty-
ine patients were revascularized (n  21 CABG, n  8
CI). Clinical follow-up over a period of 18  16 months
range 1 to 56 months) was obtained in all patients.
ighteen patients (26%) had 2-vessel disease (left main or
-vessel with proximal left anterior descending artery) and
2 patients (61%) had 3-vessel disease. During the
ollow-up period, 29 patients (41%) had CVE: 11 had
HF, 8 had ventricular arrhythmia, 1 had syncope, 3 had
I, 4 needed revascularization, and 5 died due to cardio-
ascular cause. There were no deaths or events related to
evascularization procedures.
MR parameters associated with CVE. The CMR pa-
ameters among the patients with and without CVE are
ummarized in Table 2. Total scar mass and its percentage
f myocardium were associated with more CVE (32.2 g
Figure 1 Cardiac Magnetic Resonance Characterization of Myo
The total myocardial and scar area in each of the 8 to 12 short-axis images (slice
volume for each slice were calculated as: area myocardium or area scar  slice th
the total myocardial volume: volume scar/volume myocardium  100. The scar isIQR 19.5 to 49.2 g] vs. 22.0 g [IQR 9.4 to 39.4 g], p  d.03; and 21.3% [IQR 11.6% to 35.7%] vs. 14.3% [IQR
.6% to 23.8%], p  0.03, respectively). Precise tissue
haracterization was achieved by dividing the scar mass into
ore and border zones. A larger border zone and border
one percentage of the myocardium were associated signif-
cantly with CVE (13.3 g [IQR 8.4 to 25.1 g] vs. 8.0 g [IQR
.0 to 14.5 g], p  0.02; and 7.8% [IQR 4.9% to 17.0%] vs.
.1% [IQR 1.9% to 9.3%], p  0.02, respectively). How-
ver, the mass of core infarct zone and core infarct percent-
ge of myocardium were not significantly different in pa-
ients with or without CVE (19.5 g [IQR 9.5 to 30.5 g] vs.
4.9 g [IQR 5.3 to 21.8 g], p 0.08; and 13.2% [IQR 5.5%
o 17.1%] vs. 9.4% [IQR 3.2% to 15.5%], p  0.06,
espectively). The LVEF, LVEDV, and LVESV were not
ignificantly different in patients with or without CVE
24  9% vs. 26  12%, p  0.42; 241  78 ml vs. 232 
7 ml, p  0.68; 188  72 ml vs. 178  88 ml, p  0.62,
espectively).
orrelation between scar characteristics and functional
arameters with Spearman’s method. The measurements
f LVEF, LVEDV, and LVESV did not correlate with
otal scar mass (r values of 0.12, 0.06, and 0.14, respec-
ively); total border zone mass (r values of 0.14, 0.08, and
.12, respectively); border scar percentage of the myocar-
ium (r values of 0.04, 0.10, and 0.04, respectively);
r total scar percentage of the myocardium (r values of
0.003, 0.11, and 0.04, respectively).
ffects of revascularization. When the patients were an-
lyzed between the revascularization (CABG or PCI 
CD placement) and the no-revascularization groups (med-
cal management  ICD placement), there were significant
al Infarction
ess 8 to 12 mm, gap 0 to 1 mm) were traced manually. Myocardial and scar
s. The scar percentage of myocardium was also expressed as a percentage of
osed of the inner core and outer border zones.cardi
thickn
icknes
compifferences, as shown in Table 1, except that the proportion
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June 15, 2010:2762–8 Infarct Heterogeneity in Ischemic Cardiomyopathyf men in the revascularization group is significantly higher
han in the no-revascularization group (p  0.04). How-
ver, there was no significant difference in total scar mass,
order zone mass, or core zone mass and their percent-
ges of the myocardium between the 2 groups. Overall,
here was no significant difference in the proportion of
atients who had CVE between these 2 groups (p  0.33).
ub-analysis of each group demonstrated that, in the patients
ho received medical management, the patients who had
VE had larger border zone mass (14.5 g [IQR 8.5 to 22.4 g]
s. 6.63 g [IQR 2.5 to 15.8 g], p 0.04). In contrast, in those
atients who were in the revascularization group and had
VE, there was no significant change in total scar mass, border
one mass, or core zone mass and their percentages of the
yocardium.
linical parameters associated with CVE. Analyses of
linical characteristics of all patients with and without CVE
re summarized in Table 3. There was no significant
ifference in clinical parameters between these 2 groups.
iscussion
issue heterogeneity is present and quantifiable within the
Figure 2 Determining Tissue Heterogeneity
(A) An area of late gadolinium enhancement (LGE) was identified (red) and was planim
the remote, noninfarcted myocardium (blue). (B) The maximum signal intensity (SI) w
remote ROI region was determined (ROI SI max  5). The infarct core was defined as
border was defined as the zone with an SI  maximum SI in the remote ROI but 50
is included in the border zone). (C) The total scar is depicted in green. (D) The border
the tissue mass (g) was calculated by the following: area  slice thickness  1.05. Lnfarcted myocardial tissue. In patients with a prior MI and moderately reduced LV systolic function, the extent of the
eri-infarct zone (border zone) characterized by CMR
rovides prognostic value beyond LV systolic volume index
r ejection fraction for post-MI mortality (14). Specifically,
t has been shown that border zone and tissue heterogeneity
orrelates with increased ventricular irritability by pro-
rammed electrical stimulation (9). Additionally, in those
ith ICM and severe LV dysfunction, enhanced border
one function defined as greater peak circumferential short-
ning strain and time to peak circumferential shortening
train showed positive correlation to inducibility of ventric-
lar arrhythmia (19).
Patients surviving MI and developing chronic ICM are
t risk for developing CVE. However, not all patients
ith chronic ICM have similar risk profiles. Traditional
linical indicators (LVEF, New York Heart Association
unctional class, and coronary anatomy) and electrocar-
iographic markers (QRS duration, T-wave alternans,
nd signal average electrocardiogram) have been used to
dentify patients at risk for developing ventricular ar-
hythmia and sudden death (20,21). However, these
arkers have low predictive value. They are descriptors of
d by a trained observer. The observer then planimetered a region of interest (ROI) in
e area of LGE was determined (LGE SI max  29). The maximum SI within the
ne with SI 50% of the maximal SI in the infarct (SI core  15 to 29), whereas the
aximal SI of the infarct (SI border  5 to 15, between the red lines; the value of 15
is depicted in green. The area of the core and border zones was determined, and
left main bronchus; RMB  right main bronchus.etere
ithin th
the zo
% of m
zone
MB yocardial and electrical dysfunctions rather than spe-
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Infarct Heterogeneity in Ischemic Cardiomyopathy June 15, 2010:2762–8ific physiologic markers to identify patients at risk for
eveloping CVE (20).
Prior studies have demonstrated that quantification of
yocardial scar volume and percentage by CMR is
uperior to LVEDV, LVESV, and LVEF in prognosti-
ating future CVE, particularly ventricular arrhythmia, in
atients with ICM (8,18,22–25). This study confirms
hat the quantification of the total scar mass by CMR can
e associated with the development of CVE in patients
ith ICM. More specifically, however, this study dem-
nstrated that quantitative tissue characterization of the
order zone mass and border zone percentage of infarcts
s associated with CVE. Other parameters such as core
linical and CMR Characteristics of PatientsTable 1 Clinical and CMR Characteristics of Patients
All
(n  70)
Age (yrs) 57 13
Male sex 60 (86%)
History of hypertension* 41 (59%)
History of hyperlipidemia 46 (66%)
History of diabetes 21 (30%)
History of smoking 25 (36%)
Beta-blocker use* 53 (79%)
ACE-I or ARB use* 40 (60%)
1-vessel disease* 10 (14%)
2-vessel disease*† 18 (26%)
3-vessel disease* 42 (61%)
ICD placement 26 (37%)
LVEF (%) 25 11
LVEDV (ml) 236 83
LVESV (ml) 183 81
LVED mass (g)‡ 155.0 (129.4–193.4)
Total scar mass (g)‡ 25.7 (14.1–44.1)
Border zone mass (g)‡ 9.2 (3.5–20.7)
Core scar mass (g)‡ 16.1 (7.4–23.7)
Scar % of myocardium (%)‡ 18.0 (8.0–27.4)
Border zone % of the myocardium (%)‡ 6.2 (2.4–12.7)
Core scar % of the myocardium (%)‡ 10.6 (4.0–16.6)
Cardiovascular events 29 (41%)
alues are expressed as n (%) unless otherwise noted. *Percentages assume missing data. †2-ve
SD) or ‡Mann-Whitney U test (median and interquartile range); chi-square test for nominal vari
ACE-I  angiotensin-converting enzyme inhibitor; ARB  angiotensin receptor blocker; CMR
nd-diastolic; LVEDV  left ventricular end-diastolic volume; LVEF  left ventricular ejection fracti
Association With and Without Cardiovascular EvTable 2 Association With and Without Card
With Cardiova
LVEF (%) 24
LVEDV (ml) 241
LVESV (ml) 188
Total scar mass (g)* 32.2 (19
Border zone mass (g)* 13.3 (8.4
Core zone mass (g)* 19.5 (9.5
Total scar % of the myocardium (%)* 21.3 (11
Border zone % of the myocardium (%)* 7.8 (4.9
Core zone % of the myocardium (%)* 13.2 (5.5Independent sample t test (mean  SD) or *Mann-Whitney U test (median a
Abbreviations as in Table 1.nfarct mass, core infarct percentage, LVEDV, LVESV,
nd LVEF were not associated with future CVE in
atients with ICM.
We have performed a systematic quantitative analysis of
MR images to identify specific tissue characteristics of the
nfarcted myocardium, which might serve as a longitudinal
rognostic marker for developing CVE in patients with
CM. Recent studies indicate that injured but viable myo-
ytes in the peri-infarct territory consistent with nontrans-
ural infarction might lead to CVE (14,26). The presence
f residual viable myocardium, as a path of conduction
nd/or site of peri-infarct ischemia, might be a necessary
ofactor in the pathogenesis of CVE, a conclusion that has
No Revascularization
(n  41)
Revascularization
(n  29) p Value
56 14 58 11 0.64
32 (78%) 28 (97%) 0.04
21 (53%) 20 (69%) 0.11
27 (66%) 19 (66%) 0.98
11 (27%) 10 (34%) 0.49
13 (32%) 12 (41%) 0.41
27 (71%) 26 (90%) 0.06
24 (63%) 16 (55%) 0.51
7 (18%) 3 (10%) 0.50
12 (30%) 5 (17%) 0.23
21 (53%) 21 (72%) 0.09
19 (46%) 7 (24%) 0.06
24 11 26 12 0.59
232 70 241 100 0.64
179 69 188 97 0.67
152.0 (124.8–173.4) 160.7 (132.4–217.6) 0.15
23.7 (12.0–42.0) 30.5 (15.4–45.0) 0.43
8.8 (3.2–19.5) 9.9 (4.9–22.0) 0.71
14.9 (6.8–21.2) 19.5 (9.8–27.6) 0.23
16.3 (7.8–26.7) 18.9 (18.3–32.2) 0.73
6.3 (2.2–12.3) 6.2 (2.8–16.0) 0.96
10.4 (3.9–16.6) 12.3 (4.2–16.7) 0.50
15 (36%) 14 (48%) 0.33
ease includes left main and proximal left anterior descending. Independent sample t test (mean
isher exact test when appropriate.
iac magnetic resonance; ICD  implantable cardioverter-defibrillator; LVED  left ventricular
SV  left ventricular end-systolic volume.
cular Events
Events Without Cardiovascular Events p Value
26 12 0.42
232 87 0.68
178 88 0.62
2) 22.0 (9.4–39.4) 0.03
) 8.0 (3.0–14.5) 0.02
) 14.9 (5.3–21.8) 0.08
7) 14.3 (5.6–23.8) 0.03
) 4.1 (1.9–9.3) 0.02
) 9.4 (3.2–15.5) 0.06ssel dis
ables, Fentsiovas
scular
9
78
72
.5–49.
–25.1
–30.5
.6–35.
–17.0
–17.1nd interquartile range).
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June 15, 2010:2762–8 Infarct Heterogeneity in Ischemic Cardiomyopathyeen reported in previous studies (14,26). This study dem-
nstrated that a more quantitative evaluation of the non-
ransmural extent of MI through analyzing the size of the
order zone (peri-infarct injury zone) demonstrates a higher
ssociation with CVE in this patient population of high
orbidity and mortality.
On the basis of our study, a more detailed analysis of the
njured myocardium with CMR to analyze infarct hetero-
eneity might provide therapeutic guidance in patients with
hronic, severe ICM. Subanalysis of patients who under-
ent medical management demonstrated that a larger
order zone might represent a significant association with
VE, presumably through peri-infarct ischemia as de-
cribed in the preceding text.
onclusions
uantitative tissue characterization of the border zone mass
nd border zone percentage of infarcts was associated with
higher likelihood of future CVE in patients with ICM.
owever, core infarct mass, core infarct percentage,
VEDV, LVESV, and LVEF did not demonstrate any
ignificant association. This CMR-guided technique might
ssist in clinical management of patients with ICM.
eprint requests and correspondence: Dr. Phillip C. Yang,
ivision of Cardiovascular Medicine, Stanford University Medical
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